Ed Rubel is listed as a director and promoter on 5 SEC Form D filings by 1 issuer between Nov 2013 and Apr 2020: Oricula Therapeutics LLC (Seattle, WA — biotechnology — 2013–2020; $75K reported sold to 4 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Malcolm Gleser (5 shared filings) and Vince Groppi (5 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ed. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Ed Rubel and found 4 differences: Form D filed 20 days after the first sale; 4 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.